Zydus Wellness Limited

NSE:ZYDUSWELL.NS

1987.1 (INR) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 23,27822,426.119,884.618,536.617,341.98,082.15,014.94,273.64,276.44,207.64,027.33,870.93,314.53,363.72,680.71,947.408563.329427.052
Cost of Revenue 13,55611,459.89,865.28,552.87,881.23,001.91,629.21,345.41,2271,273.91,258.41,260.91,166.91,202862.2727.27306.746249.729
Gross Profit 9,72210,966.310,019.49,983.89,460.75,080.23,385.72,928.23,049.42,933.72,768.92,6102,147.62,161.71,818.51,220.138256.583177.323
Gross Profit Ratio 0.4180.4890.5040.5390.5460.6290.6750.6850.7130.6970.6880.6740.6480.6430.6780.6270.4550.415
Reseach & Development Expenses 488594.6111.50.122.1190.9610.9830000000000
General & Administrative Expenses 3,891181.3504.1506.4130.3172.749.239.653.674.578.75.51,376.71,319.31,147833.399194.719136.808
Selling & Marketing Expenses 2,9882,587.73,415.83,338.13,407.82,008.11,199.11,052.41,333.41,278.21,173.81,110.4000000
SG&A 6,8792,587.73,919.93,844.53,538.12,180.81,248.31,0921,3871,352.71,252.51,115.91,376.71,319.31,147833.399194.719136.808
Other Expenses 13948.610489.42,9811,281974.2917.1820.3656.7665.7574.890.1-57.2-43.65.975-8.454-6.78
Operating Expenses 6,8797,8456,794.86,799.56,519.13,461.82,222.52,009.12,207.32,009.41,918.21,690.71,325.21,262.11,103.4839.374186.265130.028
Operating Income 2,8433,1253,220.43,1922,946.71,722.91,163.2919.1842.1924.3850.7919.3822.4899.6715.1380.76470.31847.295
Operating Income Ratio 0.1220.1390.1620.1720.170.2130.2320.2150.1970.220.2110.2370.2480.2670.2670.1960.1250.111
Total Other Income Expenses Net -242-216.4-160.2-2,069.9-1,734-16.6334.2320.9310.2272.2185.6159.300-22-16.02900
Income Before Tax 2,6012,908.63,060.21,122.11,212.71,706.31,497.41,2401,152.31,196.51,036.31,078.6822.4899.6693.1364.73570.31847.295
Income Before Tax Ratio 0.1120.130.1540.0610.070.2110.2990.290.2690.2840.2570.2790.2480.2670.2590.1870.1250.111
Income Tax Expense -68-195.1-28.5-65.2-204.5-6.1132.3127.2115.68553.288.3136.5304.8240.4126.7224.7723.399
Net Income 2,6693,1043,088.71,187.31,417.21,691.41,3391,089.81,016.91,089.5964.5971.1685.9594.8452.7238.01545.54823.896
Net Income Ratio 0.1150.1380.1550.0640.0820.2090.2670.2550.2380.2590.2390.2510.2070.1770.1690.1220.0810.056
EPS 41.9448.7848.5419.5524.5840.134.2727.8926.4327.8824.6924.8517.3215.2211.596.098.177.66
EPS Diluted 41.9448.7848.5419.5524.5840.134.2727.8926.4327.8824.6924.8517.3215.2211.596.098.177.66
EBITDA 3,0813,420.13,540.93,507.23,258.71,945.71,557.81,305.61,216.51,269.61,082.71,121.2861914.5731397.49177.57651.534
EBITDA Ratio 0.1320.1530.1780.1890.1880.2410.3110.3060.2840.3020.2690.290.260.2720.2730.2040.1380.121